AffyImmune Therapeutics, Inc. — Form D
AffyImmune Therapeutics, Inc. of NATICK, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-13. The offering totals $12.1M, of which $1000K was reported sold. Industry: Other Technology.
Offering
- Filed: 2018-09-13
- Form: D
- Accession: 0001752966-18-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $12.1M
- Amount sold: $1000K
- Remaining: $11.1M
- Investors: 2
- Date of first sale: 2018-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-321277
Issuer
- Name: AffyImmune Therapeutics, Inc.
- CIK: 0001752966
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 12 MICHIGAN DR, NATICK, MA, 01760
- Phone: 6176991965
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Gang Song | Director | Natick, MA |
| Gang Song | Executive Officer | Natick, MA |
| Hong Fang Song | Director | Natick, MA |
| Moonsoo Jin | Director | Natick, MA |
| Moonsoo Jin | Executive Officer | Natick, MA |
Other filings by this issuer (1)
More